Search | New Scientist

Promising treatment for chronic fatigue syndrome fails large trial

9 April 2019

Rituximab has been found to be worse than a placebo at alleviating the symptoms of CFS or ME, suggesting that antibodies aren’t to blame for the condition

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Subject

Section

Type

Topics

Author

Issue

Premium

Promising treatment for chronic fatigue syndrome fails large trial

Sign up to our weekly newsletter